Search - tctmd.com

Displaying 721 - 740 of 1475

Sort: Relevancy | Date

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Michael O'Riordan

October 18, 2018

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Michael O'Riordan

October 12, 2018

News Conference News TCT 2018

Statin Preloading Benefit More Pronounced in STEMI Patients: SECURE-PCI

Michael O'Riordan

October 05, 2018

News Daily News

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

Todd Neale

October 03, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

Case Conclusion: How I Treated This Patient

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev, Stefan Mot, Zsolt Piroth, Lucian Marius Predescu, Li-Wah Tam

September 24, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Angus Shing-Fung Chui

September 24, 2018

Presentation TCT 2018

Case Introduction: STEMI Patient With LM Occlusion and Subtotal Aorto-ostial Stenosis of the LAD Graft

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev, Stefan Mot, Zsolt Piroth, Lucian Marius Predescu, Li-Wah Tam

September 24, 2018

Presentation TCT 2018

Left Main PCI in Patients With STEMI

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev

September 24, 2018

Advertisement

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Statin Preloading Benefit More Pronounced in STEMI Patients: SECURE-PCI

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Case Conclusion: How I Treated This Patient

How Would I Treat This Patient?

Case Introduction: STEMI Patient With LM Occlusion and Subtotal Aorto-ostial Stenosis of the LAD Graft

Left Main PCI in Patients With STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content